Ovarian Carcinoma
📧 Sign up to get email alerts when something new happens for Ovarian Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-03-24Clinical Trial Update: Zoledronate or Observation in Maintaining Bone Mineral Density in Patients Who Are Undergoing Surgery to Remove Both Ovaries [Phase 2]
Phase 2 trial evaluating zoledronate versus observation for maintaining bone mineral density in patients undergoing surgery to remove both o…
-
CLINICAL_TRIALS trial_result · 2020-03-10Clinical Trial Update: Cabozantinib or Paclitaxel in Treating Patients With Persistent or Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cavity Cancer [Phase 2]
Phase 2 trial evaluating cabozantinib versus paclitaxel for persistent or recurrent epithelial ovarian, fallopian tube, or primary peritonea…
-
CLINICAL_TRIALS trial_result · 2020-03-10Clinical Trial Update: Cabozantinib-S-Malate in Treating Patients With Recurrent or Progressive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [Phase 2]
Phase 2 clinical trial update for cabozantinib-s-malate in recurrent or progressive ovarian, fallopian tube, or primary peritoneal cancer.
-
CLINICAL_TRIALS trial_result · 2019-12-23Clinical Trial Update: EHealth Mindful Movement and Breathing in Improving Outcomes in Participants Undergoing Gynecologic Surgery [NA]
Clinical trial completed evaluating mindfulness movement and breathing to improve outcomes in participants undergoing gynecologic surgery; r…
-
CLINICAL_TRIALS trial_result · 2019-12-09Clinical Trial Update: A Dose Escalation and Cohort Expansion Study of Anti-CD27 (Varlilumab) and Anti-PD-1 (Nivolumab) in Advanced Refractory Solid Tumors [Phase 1, Phase 2]
A dose-escalation and cohort-expansion study evaluating anti-CD27 (Varlilumab) with anti-PD-1 (Nivolumab) in advanced refractory solid tumor…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-11-19Clinical Trial Update: Weekly Carboplatin/Docetaxel for Recurrent Ovarian/Peritoneal Cancer [Phase 2]
Phase 2 trial update evaluating weekly carboplatin and docetaxel for recurrent ovarian or primary peritoneal cancer; study completed.
-
CLINICAL_TRIALS trial_result · 2019-10-30Clinical Trial Update: Paclitaxel With or Without Viral Therapy in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer [Phase 2]
Phase 2 trial evaluating paclitaxel with or without viral therapy in recurrent or persistent ovarian, fallopian tube, or primary peritoneal …
-
CLINICAL_TRIALS trial_result · 2019-09-17Clinical Trial Update: Elesclomol Sodium and Paclitaxel in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer [Phase 2]
Phase 2 trial evaluating elesclomol sodium with paclitaxel in patients with recurrent or persistent ovarian epithelial cancer, fallopian tub…
-
CLINICAL_TRIALS trial_result · 2019-07-23Clinical Trial Update: Sorafenib in Treating Patients With Persistent or Recurrent Ovarian Epithelial or Peritoneal Cancer [Phase 2]
Phase 2 clinical trial update evaluating sorafenib for persistent or recurrent ovarian epithelial or peritoneal cancer has completed.
-
CLINICAL_TRIALS trial_result · 2019-05-17Clinical Trial Update: Dasatinib in Treating Patients With Recurrent or Persistent Ovarian, Fallopian Tube, Endometrial or Peritoneal Cancer [Phase 2]
Phase 2 trial evaluating dasatinib in recurrent or persistent ovarian, fallopian tube, endometrial, or peritoneal cancers; study terminated …
-
CLINICAL_TRIALS trial_result · 2018-03-27Clinical Trial Update: MLN8237 for Treatment of Participants With Ovarian, Fallopian Tube, or Peritoneal Carcinoma [Phase 2]
Phase 2 trial update for MLN8237 in ovarian, fallopian tube, or peritoneal carcinoma; study completed with results posted.
-
CLINICAL_TRIALS trial_result · 2018-01-11Clinical Trial Update: Levonorgestrel in Preventing Ovarian Cancer in Patients at High Risk for Ovarian Cancer [Phase 2]
Phase 2 trial evaluating levonorgestrel to prevent ovarian cancer in high-risk patients has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2017-12-08Clinical Trial Update: Dalantercept in Treating Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer [Phase 2]
Phase 2 trial update for dalantercept in recurrent ovarian, fallopian tube, or primary peritoneal cancer; study completed with results poste…
-
CLINICAL_TRIALS trial_result · 2017-11-30Clinical Trial Update: EGEN-001 in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer [Phase 2]
Phase 2 clinical trial update for EGEN-001 in persistent or recurrent ovarian epithelial cancer, fallopian tube cancer, or primary peritonea…
-
CLINICAL_TRIALS trial_result · 2017-10-25Clinical Trial Update: (PGA) for Platinum-resistant/Refractory, Paclitaxel-Pretreated Recurrent Ovarian and Peritoneal Carcinoma [Phase 2]
Phase 2 trial update for platinum-resistant/refractory, paclitaxel-pretreated recurrent ovarian and peritoneal carcinoma; study terminated w…
-
CLINICAL_TRIALS trial_result · 2017-07-21Clinical Trial Update: Sunitinib Malate in Treating Patients With Persistent or Recurrent Clear Cell Ovarian Cancer [Phase 2]
Phase 2 trial evaluating sunitinib malate in persistent or recurrent clear cell ovarian cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2017-01-09Clinical Trial Update: A Phase 1 Study of Mixed Bacteria Vaccine (MBV) in Patients With Tumors Expressing NY-ESO-1 Antigen [Phase 1]
Phase 1 study of a mixed bacteria vaccine (MBV) targeting NY-ESO-1 tissue expression in various tumors; completed with posted results.
-
CLINICAL_TRIALS trial_result · 2016-07-21Clinical Trial Update: Search for Predictors of Therapeutic Response in Ovarian Carcinoma [NA]
Completed clinical trial at Centre François Baclesse investigating predictors of therapeutic response in ovarian carcinoma and related fallo…
-
CLINICAL_TRIALS trial_result · 2014-12-12Clinical Trial Update: Screening for Ovarian Cancer in Older Patients (PLCO Screening Trial) [NA]
Update on the PLCO ovarian cancer screening trial in older adults; results were posted in 2014 and the study remains active but not recruiti…
-
CLINICAL_TRIALS trial_result · 2014-07-17Clinical Trial Update: A6 in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer [Phase 2]
Phase 2 clinical trial update for A6 in treating persistent or recurrent ovarian epithelial cancer, fallopian tube cancer, or primary perito…
-
CLINICAL_TRIALS trial_result · 2013-10-24Clinical Trial Update: Green Tea Intake for the Maintenance of Complete Remission in Women With Advanced Ovarian Carcinoma [Phase 2]
Phase 2 clinical trial evaluating green tea intake for maintaining complete remission in women with advanced ovarian carcinoma has completed…
-
CLINICAL_TRIALS trial_result · 2012-12-13Clinical Trial Update: Sorafenib With or Without Paclitaxel and Carboplatin in Treating Patients With Recurrent Ovarian Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer [Phase 2]
Phase 2 trial evaluating sorafenib with or without paclitaxel and carboplatin for recurrent ovarian, fallopian tube, or primary peritoneal c…
-
CLINICAL_TRIALS trial_result · 2011-08-12Clinical Trial Update: Phase II Study of AZD2281 in Patients With Known BRCA Mutation Status or Recurrent High Grade Ovarian Cancer or Patients With Known BRCA Mutation Status/ Triple Neg Breast Cancer [Phase 2]
Phase II study of AZD2281 (olaparib) in patients with BRCA mutation-associated ovarian cancer or recurrent high-grade ovarian cancer, and in…